α2→3Sialyltransferase associated with the synthesis of CA 19-9 in colorectal tumors

Cancer

Volumn 77, Issue 8 SUPPL., 1996, Pages 1694-1700

  Akamatsu, Suguru ^a   Yazawa, Shin ^b   Tachikawa, Tetsuya ^a   Furuta, Takuya ^a   Okaichi, Yoshihiko ^a   Nakamura, Jun Ichi ^b   Asao, Takayuki ^b   Nagamachi, Yukio ^b  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

1 4fucosyltransferase; 2 3sialyltransferase; CA 19 9; colorectal cancer

Indexed keywords

ANTIBODY; BOVINE SERUM ALBUMIN; CA 19-9 ANTIGEN; CYTIDINE PHOSPHATE N ACETYLNEURAMINIC ACID; FUCOSYLTRANSFERASE; MONOCLONAL ANTIBODY; SIALYLTRANSFERASE; TUMOR EXTRACT; BETA GALACTOSIDE ALPHA 2,3 SIALYLTRANSFERASE; BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE; DRUG DERIVATIVE; GALACTOSIDE 3(4) LEVO FUCOSYLTRANSFERASE; GALACTOSIDE 3(4)-L-FUCOSYLTRANSFERASE; GALACTOSYL 1,3 N ACETYLGLUCOSAMINE; GALACTOSYL-1,3-N-ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINE;

BLOOD GROUP LEWIS SYSTEM; CLINICAL ARTICLE; COLORECTAL TUMOR; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNORADIOMETRIC ASSAY; PHENOTYPE; PRIORITY JOURNAL; SYNTHESIS; ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; CARBOHYDRATE ANALYSIS; CATTLE; COMPARATIVE STUDY; ENZYMOLOGY; METABOLISM; MOLECULAR GENETICS;

ACETYLGLUCOSAMINE; ANIMALS; CA-19-9 ANTIGEN; CARBOHYDRATE SEQUENCE; CATTLE; COLORECTAL NEOPLASMS; FUCOSYLTRANSFERASES; HUMANS; LEWIS BLOOD-GROUP SYSTEM; MOLECULAR SEQUENCE DATA; PHENOTYPE; SIALYLTRANSFERASES;

EID: 0029664989     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1694::AID-CNCR41>3.0.CO;2-S     Document Type: Conference Paper

References (32)

1. Del Villano BC, Brennan S, Brock P, Bucher C, Liu V, McClure M, et al. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem 1983;29:549-52.
2. Herlyn M, Sears HF, Steplewski Z, Koprowski H. Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma. J Clin Immunol 1982; 2:135-40.
3. Satomura Y, Sawabu N, Takemori Y, Ohta H, Watanabe H, Okai T, et al. Expression of various sialylated carbohydrate antigens in malignant and nonmalignant pancreatic tissues. Pancreas 1991;6:448-58.
4. a antigen. J Biol Chem 1985;260:9388-92.
5. Kannagi R, Kitakura A, Itai S, Zenita K, Shigeta K, Tachikawa T, et al. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing epitopes consisting of sialyl or sialyl-fucosyl type 1 chain. Cancer Res 1988;48:3856-63.
6. Lindholm L, Holmgren J, Svennerholm L, Fredman P, Nilsson O, Persson B, et al. Monoclonal antibodies against gastrointestinal tumor-associated antigens isolated as monosialogangliosides. Int Arch Allergy Appl Immunol 1983;71:178-81.
7. 6) of human colonic adenocarcinoma and the monoclonal antibody (FH7) defining this structure. J Biol Chem 1986;261:5487-95.
8. Itai S, Arii S, Tobe R, Kitahara A, Kim Y, Yamabe H, et al. Significance of 2-3 and 2-6 sialylation of Lewis A antigen in pancreas cancer. Cancer 1988;61:775-87.
9. Kitagawa H, Paulson JC. Cloning and expression of human Gal β 1,3(4)GlcNAc α 2,3-sialyltransferase. Biochem Biophys Res Commun 1993;194:375-82.
10. Wen DX, Livingston BD, Medzihradszky KF, Kelm S, Burlingame AL, Paulson JC. Primary structure of Gal β 1,3(4)GlcNAc α 2,3-sialyltransferase determined by mass spectrometry sequence analysis and molecular cloning. J Biol Chem 1992;267:21011-9.
11. Sasaki K, Watanabe E, Kawashima K, Sekine S, Dohi T, Oshima M, et al. Expression cloning of a novel Gal β (1-3/ 1-4) GlcNAc α 2,3-sialyltransferase using lectin resistance selection. J Biol Chem 1993;268:22782-7.
12. Gillespie W, Kelm S, Paulson JC. Cloning and expression of the Gal β 1,3GalNac α 2,3-sialyltransferase. J Biol Chem 1992;267:21004-10.
13. Kitagawa H, Paulson JC. Differential expression of five sialyltransferase genes in human tissues. J Biol Chem 1994; 269:17872-8.
14. Kitagawa H, Paulson JC. Cloning of a novel a 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups. J Biol Chem 1994;269:1394-401.
15. Tachikawa T, Yazawa S, Asao T, Shin S, Yanaihara N. Novel method for quantifying α(1→3)-L-fucosyltransferase activity in serum. Clin Chem 1991;37:2081-6.
16. Madiyalakan R, Yazawa S, Abbas SA, Barlow JJ, Matta KL. Use of N-acetyl-2′-O-methyllactosamine as a specific acceptor for the determination of α(1→3)-L-fucosyltransferase in human serum. Anal Biochem 1986;152:22-8.
17. Yazawa S, Madiyalakan R, Jain RK, Shimoda N, Matta KL. Use of benzyl 2-acetamide-2-deoxy-3-O-(2-O-methyl-β-D-galactosyl)-β-D- glucopyranoside [2′-O-methyllacto-N-biose I β Bn] as a specific acceptor for GDP-fucose:N-acetylglucosaminide α(1→4)-L-fucosyltransferase. Anal Biochem 1990;187:374-8.
18. Yazawa S, Takeya A, Hosomi O, Nakajima T, Shimoda N, Ohi H, et al. Use of synthetic H disaccharides as acceptors for detecting activities of UDP-GalNAc:Fuc α 1→3N-acetylgalactosaminyltransferase in plasma samples from blood group A subgroups. Clin Chem 1992;38:2392-95.
19. Markwell MAK. A new solid-state reagent to iodinate proteins. Anal Biochem 1982;125:427-32.
20. Yazawa S, Akamatsu S, Tachikawa T, Naitoh H, Nakamura J, Asao T, et al. Development and characterization of a novel anti-fucosylated antigen monoclonal antibody YB-2 and its usefulness in the immunohistochemical diagnosis of colorectal cancer. Jpn J Cancer Res 1993;84:641-8.
21. Joziasse DH, Bergh MLE, Hart HGJ, Koppen PL, Hooghwinkel GJM, Van den Eijnden DH. Purification and enzymatic characterization of CMP-sialic acid: β-galactosyl 1→3-N-acetylgalactosaminide α2→3-sialyltransferase from human placenta. J Biol Chem 1985;260:4941-51.
22. Lemieux RU, Baker DA, Bundle DR. A methodology for the production of carbohydrate-specific antibody. Can J Biochem 1977;55:507-12.
23. Yazawa S, Asao T, Izawa H, Miyamoto Y, Matta KL. The presence of CA 19-9 in serum and saliva from Lewis blood-group negative cancer patients. Jpn J Cancer Res 1988;79: 538-43.
24. b and Y antigens in colorectal tumors. Jpn J Cancer Res 1993;84:989-95.
25. Yazawa S, Nishihara S, Iwasaki H, Asao T, Nagamachi Y, Matta KL, et al. Genetic and enzymatic evidence for lewis enzyme expression in lewis-negative cancer patients. Cancer Res 1995;55:1473-8.
26. Yazawa S, Nakajima T, Kameyama N, Sega K, Tachikawa T. An enzyme-linked immunosorbent assay for blood group A and B enzymes. Carbohydr Res 1992;239:329-35.
27. Grundmann U, Nerlich C, Rein T, Zettlemeissl G. Complete cDNA sequence encoding human β-galactoside α-2,6-sialyltransferase. Nucleic Acids Res 1990;18:667.
28. Weinstein J, Lee EU, McEntee K, Lai P-H, Paulson JC. Primary structure of β-galactoside α2,6-sialyltransferase. J Biol Chem 1987;262:17735-43.
29. Nara K, Watanabe Y, Maruyama K, Kasahara K, Nagai Y, Sanai Y. Expression cloning of a CMP-NeuAc:NeuAc α 2-3Gal β 1-4Glc β 1-1′Cer α 2,8-sialyltransferase (GD3 synthase) from human melanoma cells. Proc Natl Acad Sci USA 1994;91:7952-6.
30. Livingston BD, Paulson JC. Polymerase chain reaction cloning of a developmentally regulated member of the sialyltransferase gene family. J Biol Chem 1993;268:11504-7.
31. Kurosawa N, Hamamoto T, Lee Y-C, Nakaoka T, Kojima N, Tsuji S. Molecular cloning and expression of GalNAc α 2,6-sialyltransferase. J Biol Chem 1994;269:1402-9.
32. Lee Y-C, Kojima N, Wada E, Kurosawa N, Nakaoka T, Hamamoto T, et al. Cloning and expression of cDNA for a new type of Gal β 1,3GalNAc α 2,3-sialyltransferase. J Biol Chem 201994;269:10028-33.